Summary
The intrathecal (i.th., T 8–10) administration in conscious rats of the 5-hydroxytryptamine (5-HT)1A agonist 8-OH-DPAT (10 nmol), and to a lesser extent the 5-HT1B agonist CGS 12066B (6 nmol), resulted in a blood pressure reduction and a bradycardia. These responses were prevented by the i.th. pretreatment with substance P (SP) (6.5 nmol) and enhanced following pretreatment with the non-peptide SP antagonist CP-96,345 (10 nmol). The partial 5-HT1A agonist 8-MeO-CLEPAT (10 nmol) had by itself small cardiovascular effects. Following the pretreatment with SP, 8-MeO-CLEPAT caused a pressor response and a tachycardia whereas the opposite effects were observed following pretreatment with the SP antagonist. These results support the notion of a functional interaction between serotonergic and SP mechanisms at the level of the preganglionic sympathetic nerves in the spinal cord.
References
Agnati LF, Fuxe K, Benfenati F, Zini I, Hökfelt T (1983) On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of [3H]5-HT binding sites. Acta Physiol Scand 117: 299–301
Appel NM, Wessendorf MW, Elde RP (1986) Coexistence of serotonin- and substance P-like immunoreactivity in nerve fibers apposing identified sympathoadrenal preganglionic neurons in rat intermediolateral cell column. Neurosci Lett 65: 241–246
Backmann SB, Henry JL (1984) Effects of substance P and thyreotropin-releasing hormone on sympathetic preganglionic neurons in upper thoracic intermediolateral nucleus of the cat. Can J Physiol Pharmacol 62: 248–251
Chalmers J, Kapoor V, Mills E, Minson J, Morris M, Pilowsky P, West M (1987) Do pressor neurons in the ventral medullae release amines and neuropeptides? Can J Physiol Pharmacol 65: 1598–1604
Cox BF, Schelper RL, Faraci FM, Brody MJ (1988) Autonomic, sensory, and motor dysfunction following intrathecal administration of three substance P antagonists. Exp Brain Res 70: 61–72
Cridland RA, Yashpal K, Ramitu W, Gauthier S, Henry JL (1987) Distribution of label after intrathecal administration of125I-substance P in the rat. Peptides 8: 213–283
Danzebrink RM, Gebhart GF (1991) Evidence that spinal 5-HT1 5-HT2, and 5-HT3 receptor subtypes moderate responses to noxious colorectal distension in the rat. Brain Res 536: 64–75
Davies JE, Roberts MHT (1981) 5-Hydroxytryptamine reduces substances P responses on dorsal horn interneurons: a possible interaction of neurotransmitters. Brain Res 217: 399–404
Eide PK, Hole K (1988) Intrathecal substance P modulates the depressant effect of 5-methoxy-N-,N-dimethyltryptamine on a reflex response to radiant heat in mice. Neurosci Lett 90: 203–207
Fozard JR, Mir AK, Middlemiss DN (1987) Cardiovascular response to 8-hydroxy-2-(din-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol 9: 328–347
Frank J, Fried G, Brodin E (1989) Substance P enhances the release of endogenous serotonin from rat ventral spinal cord. Eur J Pharmacol 174: 85–90
Gradin K, Persson B (1992) Cardiovascular effects of intrathecal administration of substance P in the rat: interactions with serotonergic mechanisms. J Neural Transm 87: 199–213
Heike CJ, Charlton CG, Wiley RG (1986) Studies on the cellular localization of spinal cord substance P receptors. Neuroscience 2: 523–533
Heike CJ, Phillips ET, O'Neil JT (1987) Intrathecal administration of a substance P antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of action. J Pharmacol Exp Ther 242: 131–136
Lundberg JM, Stjärne L (1984) Neuropeptide Y (NPY) depresses the secretion of3H-noradrenaline and the contractile response evoked by field stimulation in rat vas deferens. Acta Physiol Scand 120: 477–479
Mir AK, Fozard R (1989) Hydroxytryptamine in central cardiovascular regulation. In: Saxena PR, Wallis W, Wouters W, Bevan P (eds) Cardiovascular pharmacology of 5-hydroxytryptamine: prospective therapeutic applications. Kluwer, Dordrecht, pp 247–257
Monroe PJ, Smith DJ (1985) Demonstration of an autoreceptor modulating the release of [3H] 5-hydroxytryptamine from a synaptosomal-rich spinal cord tissue preparation. J Neurochem 45: 1886–1894
Neale RF, Fallon SL, Bogar WC, Wosley JWF, Martin LL, Stanc GA, Glaeser BS, Sinton CM, Williams M (1987) Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1 B agonist. Eur J Pharmacol 136: 1
Schwab EF, Zemlan FP, Murphy RM (1989) Dominant spinal cord 5-HT receptor, the 5-HT-1A: relations to pain. Soc Neurosci Abstr 15: 546
Snider M, Constantine JW, Lowe JA, Longo KP, Lebel WS, Woody HA, Drozda SE, Desai MC, Vinick FJ, Spencer RW, Hess H-J (1991) Potent nonpeptide antagonist of the substance P (NK1 receptor. Science 251: 435–437
Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotonergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1: 3–9
Tremblay LE, Maheux R, Bédard PJ (1986) Substance P in the lumbar spinal cord of the rat affects the motor response to 5-HTP and TRH. Neuropharmacology 25: 419–424
Trolin G (1975) Involvement of alpha-adrenergic receptors at different levels of the central nervous system in regulation of blood pressure and heart rate. Acta Physiol Scand [Suppl 430]
Ward RA, Roberts MHT (1984) Physiological interaction of the coexisting neurochemicals 5-hydroxytryptamine and substance P. J Anat 138: 576
Xu X-J, Dalsgaard C-J, Wiesenfeld-Hallin (1992) Intrathecal CP-96,345 blocks reflex facilitation induced in rats by substance P and C-fiber-conditioning stimulation. Eur J Pharmacol 216: 337–344
Yaksh TL, Rudy TA (1976) Chronic catheterization of the spinal subarachnoidal space. Physiol Behav 17: 1031–1036
Yashpal K, Gauthier SG, Henry JL (1987) Substance P given intrathecally at the spinal T9 level increases arterial pressure and heart rate in the rat. J Auton Nerv Syst 18: 93–103
Yosuf APM, Coote JH (1988) Excitatory and inhibitory actions of intrathecally administered 5-hydroxytryptamine on sympathetic nerve activity in the rat. J Auton Nerv Syst 22: 229–236
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gradin, K., Persson, B. Cardiovascular effects of intrathecal administration of agents active at 5-hydroxytryptamine1-receptors in the rat: modulation by substance P and a substance P antagonist. J. Neural Transmission 93, 225–234 (1993). https://doi.org/10.1007/BF01244999
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01244999